Serum NMR metabolomics uncovers multiple metabolic changes in phenobarbital-treated dogs.

The identified metabolites are known to associate with, for example, liver and CNS function, inflammatory processes and drug binding. The lack of a linear association to phenobarbital concentration suggests that other factors than the blood phenobarbital concentration contribute to the magnitude of metabolic changes.